Probiotic and enterohemorrhagic Escherichia coli: An effective strategy against a deadly enemy?

Abstract

Enterohemorrhagic Escherichia coli (EHEC) are major food-borne pathogens that constitute a serious public health threat. Currently, there is no specific treatment available for EHEC infections in human creating an urgent need for the development of alternative therapeutic strategies. Among them, one of the most promising approaches is the use of probiotic microorganisms. Even if many studies have shown the antagonistic effects of probiotic bacteria or yeast on EHEC survival, virulence, adhesion on intestinal epithelium or pathogen-induced inflammatory responses, mechanisms mediating their beneficial effects remain unclear. This review describes EHEC pathogenesis and novel therapeutic strategies, with a particular emphasis on probiotics. The interests and limits of a probiotic-based approach and the way it might be incorporated into global health strategies against EHEC infections will be discussed.

Keywords:

• Food-borne pathogen
• enterohemorrhagic Escherichia coli
• innovative treatment
• probiotic
• gastrointestinal tract

Disclosure statement

The authors report that they have no conflict of interest. The authors alone are responsible for the content and writing of this article.